Log In
Print
BCIQ
Print
Print this Print this
 

Anti-IFN alpha, rontalizumab (RG7415)

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionInterferon (IFN) alpha humanized mAb
Molecular Target Interferon (IFN) alpha
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationLupus
Indication DetailsTreat systemic lupus erythematosus (SLE)
Regulatory Designation

Partner

Chugai Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today